Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 2,932 | 5,365 | 12,427 | 0 | 0 |
| Gross Profit | 2,932 | 5,365 | 12,427 | N/A | N/A |
| Operating Expenses | 16,613 | 12,563 | 11,874 | 0 | 0 |
| Operating Income | -13,681 | -7,198 | 554 | N/A | N/A |
| Interest Expense | 185 | 2,655 | 494 | 0 | 0 |
| Other Income | 11 | 3 | 6 | 0 | 0 |
| Pre-tax Income | -13,855 | -9,850 | 66 | 0 | 0 |
| Income Tax | 204 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -14,059 | -9,850 | 66 | N/A | N/A |
| Net Income | $-14,059 | $-9,850 | $66 | $N/A | $N/A |
| EPS Basic Total Ops | -32.80 | -56.80 | 0.80 | N/A | N/A |
| EPS Basic Continuous Ops | -32.70 | -56.80 | 0.45 | N/A | N/A |
| EPS Diluted Total Ops | -32.80 | -56.80 | 0.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -32.70 | -56.80 | 0.45 | N/A | N/A |
| EBITDA(a) | $-13,373 | $-6,831 | $939 | $N/A | $N/A |